The myo-inositol biosynthesis rate-limiting enzyme ISYNA1 suppress the stemness of ovarian cancer
Lingling Yang(Beijing Institute of Petrochemical Technology), Qi Zhou(Fudan University), Yunzhe Li(Tianjin Medical University), Tingyuan Lang(Chongqing University), Xingtao Long(Chongqing University), Chenxi Cui(Chongqing University), Muyao Yang(Chongqing University)
Cited by 0
Related Papers
Highly graphitized nitrogen-doped porous carbon nanopolyhedra derived from ZIF-8 nanocrystals as efficient electrocatalysts for oxygen reduction reactions
|Nanoscale|2014|816
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆
|Annals of Oncology|2021|212
The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure
|Stem Cell Research & Therapy|2018|158